Introduction: Despite generally considered as a safe vaccine, yellow fever vaccine (YFV) can rarely be associated with severe adverse reactions including yellow fever vaccine-associated viscerotropic disease (YEL-AVD). Although the mechanisms behind YEL-AVD cases remains elusive, its occurrence among family members suggests that genetic defects may play a role. Here, we report the investigative strategy and preliminary reports from a national-based, phase IV study, aimed at elucidating the mechanisms behind YEL-AVD. Objective: To elucidate the mechanisms behind yellow fever vaccine-associated viscerotropic disease (YEL-AVD).
